These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26289215)

  • 1. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
    Abdul Nasir NA; Agarwal P; Agarwal R; Iezhitsa I; Alyautdin R; Nukolova NN; Chekhonin VP; Mohd Ismail N
    Drug Deliv; 2016 Oct; 23(8):2765-2771. PubMed ID: 26289215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
    Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
    Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes in topical ophthalmic drug delivery: an update.
    Agarwal R; Iezhitsa I; Agarwal P; Abdul Nasir NA; Razali N; Alyautdin R; Ismail NM
    Drug Deliv; 2016 May; 23(4):1075-91. PubMed ID: 25116511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spanlastics--a novel nanovesicular carrier system for ocular delivery.
    Kakkar S; Kaur IP
    Int J Pharm; 2011 Jul; 413(1-2):202-10. PubMed ID: 21540093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.
    Chung YB; Han K; Nishiura A; Lee VH
    Pharm Res; 1998 Dec; 15(12):1882-7. PubMed ID: 9892473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloidal drug delivery system: amplify the ocular delivery.
    Ali J; Fazil M; Qumbar M; Khan N; Ali A
    Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impregnation of collagen corneal shields with liposomes: uptake and release of hydrophilic and lipophilic marker substances.
    Grammer JB; Kortüm FA; Wolburg H; Lüdtke R; Schmidt KH; Thiel HJ; Pleyer U
    Curr Eye Res; 1996 Aug; 15(8):815-23. PubMed ID: 8921224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes.
    Mura P; Maestrelli F; González-Rodríguez ML; Michelacci I; Ghelardini C; Rabasco AM
    Eur J Pharm Biopharm; 2007 Aug; 67(1):86-95. PubMed ID: 17350813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye.
    Baba K; Tanaka Y; Kubota A; Kasai H; Yokokura S; Nakanishi H; Nishida K
    J Control Release; 2011 Aug; 153(3):278-87. PubMed ID: 21549167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-small micelles based on polyoxyl 15 hydroxystearate for ocular delivery of myricetin: optimization, in vitro, and in vivo evaluation.
    Hou Y; Zhang F; Lan J; Sun F; Li J; Li M; Song K; Wu X
    Drug Deliv; 2019 Dec; 26(1):158-167. PubMed ID: 30822157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle size of liposomes influences dermal delivery of substances into skin.
    Verma DD; Verma S; Blume G; Fahr A
    Int J Pharm; 2003 Jun; 258(1-2):141-51. PubMed ID: 12753761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transcorneal drug delivery: prospects for the use of liposomes].
    Aliautdin RN; Iezhitsa IN; Agarval R
    Vestn Oftalmol; 2014; 130(4):117-22. PubMed ID: 25306734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes.
    Lajunen T; Hisazumi K; Kanazawa T; Okada H; Seta Y; Yliperttula M; Urtti A; Takashima Y
    Eur J Pharm Sci; 2014 Oct; 62():23-32. PubMed ID: 24810393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination.
    Kalam MA; Alshamsan A; Aljuffali IA; Mishra AK; Sultana Y
    Drug Deliv; 2016; 23(3):896-907. PubMed ID: 24865289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model.
    Kesisoglou F; Zhou SY; Niemiec S; Lee JW; Zimmermann EM; Fleisher D
    Pharm Res; 2005 Aug; 22(8):1320-30. PubMed ID: 16078142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopharmaceutical considerations in topical ocular drug delivery.
    Davies NM
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):558-62. PubMed ID: 10874518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
    Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
    Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.